ArticleMaternal-fetal medicine (Wolters Kluwer Health, Inc.)2026
Clinical Characteristics of Early-Onset Severe Hemolytic Disease of the Fetus and Newborn and Treatment Efficacy of Serial Intrauterine Transfusions: A 10-Year Single-Center Experience in China.
Article in Maternal-fetal medicine (Wolters Kluwer Health, Inc.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To summarize the clinical characteristics of early-onset severe hemolytic disease of the fetus and newborn (HDFN) in a Chinese cohort and identify factors influencing intrauterine transfusion (IUT) frequency and pregnancy outcomes. Methods: This retrospective cohort study included cases managed between 2013 and 2022. Factors affecting IUT efficacy were analyzed with regard to subsequent IUT risk and adverse pregnancy outcomes. Survival analysis for recurrent events was performed to assess subsequent IUT risk. Results: Of the 97 cases included, 38 were identified as early-onset severe HDFN. Compared with non-early-onset severe HDFN, early-onset severe HDFN was characterized by higher anti-D titer (1:1024 Conclusion: The characteristics of early-onset severe HDFN in Chinese patients are different from those observed in western cohorts. These patients frequently present with higher anti-D titers and a more complex spectrum of multiple alloantibodies. The occurrence of early-onset severe HDFN is associated with an increased frequency of IUT and lower live birth rates. Therefore, exploring effective interventions to delay the first IUT is critical to optimizing the timing and efficacy of intrauterine management for these high-risk cases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.